Headline News
Johnson & Johnson to buy V-Wave for up to $1.7bn
Johnson & Johnson said on Tuesday that it has agreed to buy V-Wave, a privately-held company focused on developing treatment options for patients with heart failure, for up to $1. 7bn.
Hobbycraft on brink of being bought by Modella Capital - report
Arts and crafts retailer Hobbycraft is reportedly on the brink of being sold to a specialist investor whose executives have backed chains including Paperchase and Tie Rack.
Gold prices hit fresh highs amid US rate cut expectations
Gold prices hit a new all-time high on Tuesday amid growing expectations of US rate cuts in September and after the People’s Bank of China issued new import quotas.
Sweden’s Riksbank cuts rates by 25 basis points
Sweden’s Riksbank cut its benchmark rate by 25 basis points on Tuesday to 3. 5%, as widely expected.
BT Group slides as CityFibre strikes deal with Sky
BT Group slumped on Tuesday after competitor CityFibre announced a long-term broadband partnership with Sky.
Wood Group swings to H1 operating loss but FY guidance maintained
Wood Group said on Tuesday that it swung to an operating loss in the first half as revenue fell, but the engineering firm backed its outlook for this year and the next.
Diversified Energy acquires $69m package of East Texas gas assets
Diversified Energy announced a conditional agreement to acquire a package of natural gas assets in eastern Texas on Tuesday, for $69m.
GSK lung cancer drug gets FDA breakthrough designation
Pharmaceutical giant GSK announced on Tuesday that the US Food and Drug Administration (FDA) has granted breakthrough therapy designation to its investigational drug, GSK5764227 (GSK'227), for the treatment of patients with extensive-stage small-cell lung cancer (ES-SCLC) who had experienced disease progression following platinum-based chemotherapy.